This review highlighted that whilst there is some qualitative evidence related to the experiences, views and perceptions of patients and clinicians of GLP‐1 RAs, this was mostly with respect to diabetes management and mostly from a patient perspective. This evidence concerns the gene GCG and diabetes mellitus.